15 July, 2017
$2.81 million worth of General Electric Company (NYSE:GE) shares were bought by IMMELT JEFFREY R. 5,000 General Electric Company (NYSE:GE) shares with value of $148,150 were bought by Bornstein Jeffrey S. $7,046 worth of General Electric Company (NYSE:GE) shares were bought by DIMITRIEF ALEXANDER. Oppenheimer Holdings, Inc. set a $43.00 price target on Teva Pharmaceutical Industries Limited and gave the company a "buy" rating in a report on Thursday, April 6th.
Other large investors have also made changes to their positions in the company.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) last issued its quarterly earnings results on Thursday, May 11th. First City Capital Management Inc bought 14,635 shares as the company's stock declined 15.11% while stock markets rallied.
The share of Teva Pharmaceutical Industries Limited (TEVA) now has a value of $33.19 while the company's 52 week low is at $27.59, the shares dropped to the 52 week low on 05/31/17. Bronfman E.L. Rothschild L.P. now owns 3,617 shares of the company's stock valued at $116,000 after buying an additional 261 shares in the last quarter. FNY Managed Accounts LLC bought a new position in shares of Teva Pharmaceutical Industries Limited during the first quarter worth about $123,000. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since July 14, 2016 and is downtrending. Sterling Investment Advisors Ltd. now owns 3,900 shares of the company's stock worth $125,000 after buying an additional 100 shares during the period. Finally, Mizuho raised shares of Teva Pharmaceutical Industries Limited from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $25.00 to $30.00 in a research note on Thursday, June 15th. Financial Architects Inc now owns 4,443 shares of the company's stock valued at $143,000 after buying an additional 100 shares during the last quarter. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has "Hold" rating given on Friday, November 4 by HSBC. Institutional investors own 56.26% of the company's stock. The stock has a market capitalization of $33.40 billion, a PE ratio of 421.474 and a beta of 0.47. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned "Hold" rating by Jefferies on Wednesday, November 16. Teva Pharmaceutical Inds Ltd now has $33.60 billion valuation. Traders purchased 2,342 call options on the stock. This represents an increase of approximately 416% compared to the typical daily volume of 5,566 call options. After $0.21 actual EPS reported by Trueblue Inc for the previous quarter, Wall Street now forecasts 104.76% EPS growth. The business had revenue of $5.63 billion for the quarter, compared to the consensus estimate of $5.69 billion.
Teva Pharmaceutical Industries Limited is a pharmaceutical company. Bank of America downgraded Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Monday, November 7 to "Neutral" rating. They expect $0.26 EPS, down 49.02% or $0.25 from last year's $0.51 per share. Teva Pharmaceutical Industries Limited's payout ratio is now 5,802.90%.
The business also recently declared a quarterly dividend, which was paid on Thursday, June 22nd.
Needle moving action has been spotted in Riverside Resources Inc (RRI.V) as shares are moving today on volatility 5.88% or $0.02 from the open. More interesting news about Stryker Corporation (NYSE:SYK) were released by: Seekingalpha.com and their article: "With Stryker, One Of The Best Always Seems To Get Better" published on July 05, 2017 as well as Nasdaq.com's news article titled: "Stryker Corporation (SYK) Ex-Dividend Date Scheduled for June 28, 2017" with publication date: June 27, 2017. Teva Pharmaceutical Industries Limited earned a media sentiment score of 0.18 on Accern's scale.
COPYRIGHT VIOLATION NOTICE: This report was posted by Transcript Daily and is the property of of Transcript Daily. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & worldwide trademark and copyright laws. The original version of this report can be accessed at https://transcriptdaily.com/2017/07/14/teva-pharmaceutical-industries-limited-teva-given-news-sentiment-score-of-0-18-updated-updated.html. Seventeen equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Vetr downgraded shares of Teva Pharmaceutical Industries Limited from a "hold" rating to a "sell" rating and set a $31.05 target price for the company.in a report on Thursday, June 22nd.
Teva Pharmaceutical Industries Limited is a pharmaceutical company.
Among 17 analysts covering Synergy Resources (NYSEMKT:SYRG), 15 have Buy rating, 0 Sell and 2 Hold. The stock presently has a consensus rating of "Hold" and a consensus target price of $43.51. The Firm is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Firm operates through two divisions: Generic medicines and Specialty medicines.
